Corvus Pharmaceuticals Inc buy Lokrim
Start price
15.05.23
/
20%
€2.40
Target price
15.05.24
-
Performance (%)
30.00%
End price
12.06.23
€3.12
Summary
This prediction ended on 12.06.23 with a price of €3.12. The prediction had a final performance of 30.00%. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Corvus Pharmaceuticals Inc | - | - | 225.207% |
| iShares Core DAX® | 0,46 % | -2,00 % | 9,98 % |
| iShares Nasdaq 100 | -1,79 % | -5,74 % | -0,78 % |
| iShares Nikkei 225® | 5,12 % | 9,09 % | 28,82 % |
| iShares S&P 500 | -1,76 % | -3,67 % | -0,54 % |
According to Lokrim what are the pros and cons of Corvus Pharmaceuticals Inc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Medium risks for its business
Cons
Comments by Lokrim for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Buy Corvus Pharmaceuticals Inc
In the thread Trading Corvus Pharmaceuticals Inc
Buy beendet
Stopped prediction by Lokrim for Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€13.60
20.01.26
20.01.26
-
20.01.27
20.01.27
55.15%
26.01.26
26.01.26
Could be worthwhile Investment >10% per year
Medium risks for its business
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€3.12
12.06.23
12.06.23
-
12.06.24
12.06.24
-41.35%
11.12.23
11.12.23
Could be worthwhile Investment >10% per year
Medium risks for its business

